InvestorsHub Logo
Followers 231
Posts 34993
Boards Moderated 1
Alias Born 11/19/2003

Re: None

Monday, 04/06/2015 9:39:01 AM

Monday, April 06, 2015 9:39:01 AM

Post# of 955
Roth Capital Weighs In On 5 Biotech Stocks To Watch | Seeking Alpha

Curis, Inc. (NASDAQ:CRIS)

Pantginis maintained a Buy rating on CRIS with a price target of $6. Pantginis commented that the oncology-focused drug development is currently focusing on proprietary programs in addition to earning royalty-based revenue from Erivedge, an oral hedgehog inhibitor. Curis is in the midst of testing many treatments, such as drugs for multiple myeloma, lymphoma, and solid tumors.

Pantginis has rated Curis 10 times since June 2011, earning a 90% success rate recommending the stock and a +49.8% average return per recommendation.

On average, the top analyst consensus for Curis on TipRanks is Strong Buy.

http://seekingalpha.com/article/3051976-roth-capital-weighs-in-on-5-biotech-stocks-to-watch

.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRIS News